In AD pathology, soluble tau and insoluble tau from PHFs act as substrates for E3 ubiquitin ligase-mediated ubiquitination and proteasome degradation via K11, K48, and K6-linked polyubiquitin chains (12, 17, 22, 39). Here, MAPT is linked to Alzheimer disease.